Meta Biomed Co., Ltd. (KOSDAQ:059210)

Market Cap	127.20B +34.7%
Revenue (ttm)	99.77B +8.1%
Net Income	18.38B +19.8%
EPS	615.37 +52.6%
Shares Out	27.06M
PE Ratio	7.63
Forward PE	5.75
Dividend	30.00 (0.64%)
Ex-Dividend Date	Dec 29, 2025

Volume	131,815
Average Volume	387,967
Open	4,510.00
Previous Close	4,515.00
Day's Range	4,470.00 - 4,585.00
52-Week Range	4,045.00 - 6,600.00
Beta	0.61
RSI	46.65
Earnings Date	Mar 20, 2026

About Meta Biomed

Meta Biomed Co., Ltd. engages in the research, development, and production of dental and surgical materials in South Korea, Asia, Europe, the United States, and Africa. The company's dental products include endodontics, dental equipment, restorative materials, and bone graft materials. It also offers suture products comprising multifilament and monofilament products; suture materials, such as functional and orthopedic suture materials; biomaterials, that includes polymer, multifilament yarn, 3D printing filaments, and bioceramic powder; and aux...

• Industry: Dental Equipment and Supplies
• Founded: 1990
• Employees: 305
• Stock Exchange: KOSDAQ
• Ticker Symbol: 059210

Financial Performance

In 2024, Meta Biomed's revenue was 94.04 billion, an increase of 13.16% compared to the previous year's 83.10 billion. Earnings were 22.40 billion, an increase of 122.24%.